U.S. market Closed. Opens in 1 day 6 hours 30 minutes

DICE | DICE Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/A1.12M863.00K5.78M
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/A1.12M863.00K5.78M
Operating Expenses88.22M48.73M24.58M19.32M
Selling, General & Admin25.66M12.22M5.00M3.61M
Research & Development62.56M36.51M19.58M15.71M
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-88.22M-47.60M-23.72M-13.55M
Other Expenses / Income4.33M-1.36M-18.00K609.00K
Before Tax Income-83.89M-48.96M-23.74M-12.94M
Income Tax Expenses-2.22M-487.00K13.00K26.00K
Net Income-81.66M-48.47M-23.75M-12.96M
Interest Expenses679.00K174.00K13.00K26.00K
Basic Shares Outstanding39.40M12.38M23.23M23.23M
Diluted Shares Outstanding39.40M12.38M23.23M23.23M
EBITDA-83.01M-47.47M-22.89M-12.21M
EBITDA Margin0.00%-4,219.29%-2,651.80%-211.36%
EBIT-83.21M-48.78M-23.73M-12.91M
EBIT Margin0.00%-4,336.44%-2,749.25%-223.58%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙